![Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies - Reig‐Lopez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies - Reig‐Lopez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/adf07831-7984-4d57-a8b9-0db687322051/bcp15745-toc-0001-m.jpg)
Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies - Reig‐Lopez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library
![Pharmaceuticals | Free Full-Text | Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence Pharmaceuticals | Free Full-Text | Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-01133/article_deploy/html/images/pharmaceuticals-15-01133-ag.png?1662813796)
Pharmaceuticals | Free Full-Text | Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
![6‐Substituted Pyrrolo[3,4‐c]pyrazoles: An Improved Class of CDK2 Inhibitors - Brasca - 2007 - ChemMedChem - Wiley Online Library 6‐Substituted Pyrrolo[3,4‐c]pyrazoles: An Improved Class of CDK2 Inhibitors - Brasca - 2007 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/faec6c12-239b-45ff-87d6-062dfe63dc95/mcontent.jpg)
6‐Substituted Pyrrolo[3,4‐c]pyrazoles: An Improved Class of CDK2 Inhibitors - Brasca - 2007 - ChemMedChem - Wiley Online Library
![Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study | Future Journal of Pharmaceutical Sciences | Full Text Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study | Future Journal of Pharmaceutical Sciences | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43094-020-00069-3/MediaObjects/43094_2020_69_Figa_HTML.png)
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study | Future Journal of Pharmaceutical Sciences | Full Text
![Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery | Future Medicinal Chemistry Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.15.143/asset/images/medium/figure2.gif)
Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery | Future Medicinal Chemistry
![Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/928d891d-cb46-4fa9-9f7d-7807c726c8cf/gr1.jpg)
Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences
![Optimizing Pharmacokinetic Property Prediction Based on Integrated Datasets and a Deep Learning Approach | Journal of Chemical Information and Modeling Optimizing Pharmacokinetic Property Prediction Based on Integrated Datasets and a Deep Learning Approach | Journal of Chemical Information and Modeling](https://pubs.acs.org/cms/10.1021/acs.jcim.0c00568/asset/images/medium/ci0c00568_0011.gif)
Optimizing Pharmacokinetic Property Prediction Based on Integrated Datasets and a Deep Learning Approach | Journal of Chemical Information and Modeling
![Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults | SpringerLink Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13318-023-00841-9/MediaObjects/13318_2023_841_Fig1_HTML.png)
Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults | SpringerLink
![IJERPH | Free Full-Text | The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment IJERPH | Free Full-Text | The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment](https://www.mdpi.com/ijerph/ijerph-20-03473/article_deploy/html/images/ijerph-20-03473-g001.png)
IJERPH | Free Full-Text | The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells | ACS Pharmacology & Translational Science
![Pharmacokinetics-guided optimization of QD394 led to QD394-Me having... | Download Scientific Diagram Pharmacokinetics-guided optimization of QD394 led to QD394-Me having... | Download Scientific Diagram](https://www.researchgate.net/profile/Shuai-Hu-16/publication/343727410/figure/fig4/AS:981808564953090@1611092811851/QD394-Me-has-a-similar-cellular-profile-to-QD394-A-QD394-Me-increased-the-cellular-ROS_Q320.jpg)
Pharmacokinetics-guided optimization of QD394 led to QD394-Me having... | Download Scientific Diagram
Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties | Journal of Medicinal Chemistry
![Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia | Scientific Reports Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-38414-0/MediaObjects/41598_2023_38414_Fig1_HTML.png)
Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia | Scientific Reports
![Full article: Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes Full article: Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FIJN.S337130&id=dijn_a_337130_uf0001_c.jpg)
Full article: Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes
![Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective | Future Virology Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective | Future Virology](https://www.futuremedicine.com/cms/10.2217/fvl.13.67/asset/images/medium/figure2.gif)
Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective | Future Virology
![Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp→π*Ar interaction | SpringerLink Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp→π*Ar interaction | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00044-023-03088-w/MediaObjects/44_2023_3088_Figa_HTML.png)
Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp→π*Ar interaction | SpringerLink
![Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01444-4/MediaObjects/41416_2021_1444_Fig1_HTML.png)
Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer
![Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders | Drug Metabolism & Disposition Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/51/7/792/F1.large.jpg)